Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
5.72B | 6.79B | 6.53B | 4.74B | 3.57B | Gross Profit |
1.28B | 1.65B | 1.53B | 1.24B | 883.11M | EBIT |
314.90M | 949.73M | 1.03B | 884.47M | 430.94M | EBITDA |
1.01B | 1.10B | 1.09B | 850.45M | 503.64M | Net Income Common Stockholders |
278.88M | 647.73M | 737.69M | 650.91M | 296.82M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
75.97M | 126.50M | 127.02M | 68.91M | 81.62M | Total Assets |
10.07B | 11.06B | 9.20B | 6.13B | 5.61B | Total Debt |
4.26B | 4.64B | 3.58B | 1.62B | 1.66B | Net Debt |
4.18B | 4.51B | 3.45B | 1.55B | 1.58B | Total Liabilities |
5.61B | 6.37B | 5.31B | 2.79B | 2.66B | Stockholders Equity |
4.38B | 4.61B | 3.81B | 3.28B | 2.89B |
Cash Flow | Free Cash Flow | |||
506.81M | 342.26M | 420.94M | 430.02M | 340.73M | Operating Cash Flow |
839.29M | 899.26M | 813.74M | 704.42M | 624.65M | Investing Cash Flow |
-498.90M | -1.68B | -2.42B | -490.26M | -310.63M | Financing Cash Flow |
-399.56M | 876.29M | 1.68B | -221.36M | -306.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $8.90B | 14.11 | 16.31% | 2.32% | -6.88% | -4.93% | |
76 Outperform | $3.01B | 13.15 | 8.59% | 3.27% | -0.24% | 26.74% | |
75 Outperform | $5.38B | 32.08 | 3.79% | โ | -11.02% | -68.34% | |
73 Outperform | $5.94B | 10.34 | 21.60% | 2.59% | 5.85% | โ | |
70 Outperform | $6.25B | 19.98 | 9.15% | โ | 1.48% | 9.36% | |
68 Neutral | $7.23B | 20.12 | 21.63% | 2.85% | -2.49% | -65.96% | |
64 Neutral | $8.78B | 14.76 | 5.05% | 174.28% | 3.62% | 3.48% |
On May 12, 2025, Darling Ingredients Inc. announced a non-binding term sheet with Tessenderlo Group to form a joint venture, Nextida, combining their collagen and gelatin businesses. Darling will hold an 85% stake, and Tessenderlo 15%. This strategic partnership aims to create a leading company in the collagen-based health, wellness, and nutrition sectors, with expected annual revenue of $1.5 billion. The venture is anticipated to close in 2026, subject to customary conditions and regulatory approvals, and is expected to enhance product development and shareholder value while expanding market reach.
Spark’s Take on DAR Stock
According to Spark, TipRanks’ AI Analyst, DAR is a Outperform.
Darling Ingredients demonstrates strong financial health with zero debt and efficient cash management. While technical indicators show a stable trend, high valuation and challenges in the DGD segment weigh on the stock. The positive board appointment adds a slight boost, but market pressures need careful monitoring.
To see Spark’s full report on DAR stock, click here.
At the annual meeting held on May 7, 2025, Darling Ingredients Inc. stockholders elected the Board of Directors and voted on two proposals. The proposals included ratifying KPMG LLP as the independent registered public accountant for the fiscal year ending January 3, 2026, and approving the company’s executive compensation. These decisions reflect the company’s ongoing commitment to maintaining strong governance and financial oversight, which could impact its operational efficiency and stakeholder confidence.
Spark’s Take on DAR Stock
According to Spark, TipRanks’ AI Analyst, DAR is a Outperform.
Darling Ingredients demonstrates strong financial health with zero debt and efficient cash management. While technical indicators show a stable trend, high valuation and challenges in the DGD segment weigh on the stock. The positive board appointment adds a slight boost, but market pressures need careful monitoring.
To see Spark’s full report on DAR stock, click here.
On February 20, 2025, Darling Ingredients Inc. announced the election of Soren Schroder to its Board of Directors as an independent director, effective immediately. Schroder, who brings extensive experience in operations and corporate governance from his tenure as CEO of Bunge Global SA, will serve on the board’s compensation and audit committees. His appointment is expected to enhance Darling Ingredients’ strategic capabilities and help navigate market complexities for long-term growth.